These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3143159)

  • 21. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
    Garre L; Alvarez A; Cianciulli T; Quiroga J; Califano J; Mautner B
    Arch Inst Cardiol Mex; 1989; 59(3):241-4. PubMed ID: 2506843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of refractory supraventricular arrhythmias with flecainide acetate.
    Till JA; Rowland E; Shinebourne EA; Ward DE
    Arch Dis Child; 1987 Mar; 62(3):247-52. PubMed ID: 3105471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
    Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B
    Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposite effects of propafenone and flecainide in a patient with reciprocating supraventricular tachycardia.
    Montenero AS; Natale A; di Bona G; Calvi V; Santarelli P; Manzoli U
    Cardiologia; 1990 Mar; 35(3):253-6. PubMed ID: 2123130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flecainide for supraventricular tachyarrhythmias.
    Med Lett Drugs Ther; 1992 Jul; 34(875):71-2. PubMed ID: 1630411
    [No Abstract]   [Full Text] [Related]  

  • 26. [Arrhythmogenic effect of flecainide--treatment with i.v. magnesium].
    Mletzko R; Jung W; Manz M; Kamradt T; Vogel F; Lüderitz B
    Z Kardiol; 1989 Sep; 78(9):602-6. PubMed ID: 2510412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiarrhythmic treatment with flecainide (Tambocor). Clinical experience from 107 patients.
    Frandsen F; Pless P; Mickley H; Møller M
    Acta Cardiol; 1990; 45(5):351-7. PubMed ID: 1704167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Flecainide and paroxysmal supraventricular tachycardia in the operating room].
    Borgeat A; Thorin D
    Schweiz Med Wochenschr; 1988 Jun; 118(24):944-6. PubMed ID: 3135590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with flecainide for symptomatic and refractory tachyarrhythmias in children.
    Ismail Z; Alwi M; Lim MK; Murtazam HA; Jamaluddin A
    Acta Paediatr Jpn; 1994 Feb; 36(1):44-8. PubMed ID: 8165907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Flecainide acetate utilisation review among general practitioners and hospital or office-based cardiologists in France. Obepine: observational study of flecainide].
    Liard F; Le Heuzey JY; Jaillon P; Lièvre M; Danchin N
    Ann Cardiol Angeiol (Paris); 2006 Jun; 55(3):113-22. PubMed ID: 16792025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug therapy in supraventricular arrhythmia].
    Follath F; Candinas R; Meyer B
    Schweiz Rundsch Med Prax; 1992 Apr; 81(18):579-81. PubMed ID: 1594845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Flecainide acetate].
    Bordier P; Garrigue S; Clémenty J
    Ann Cardiol Angeiol (Paris); 1996 May; 45(5):263-79. PubMed ID: 8763646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the use of flecainide acetate in the long-term management of cardiac arrhythmias.
    Wiseman MN; Elstob JE; Camm AJ; Nathan AW
    Pacing Clin Electrophysiol; 1990 Jun; 13(6):767-75. PubMed ID: 1695357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tachycardia with wide QRS. Limitations of electrocardiographic criteria in patients treated with anti-arrhythmia agents].
    Le Davay M; Victor J; Dupuis JM; Merheb M; Tran P; Tadeï A
    Ann Cardiol Angeiol (Paris); 1994 May; 43(5):253-5. PubMed ID: 8074416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oral flecainide in the treatment of refractory arrhythmias. Long-term follow-up of 98 patients].
    Haissaguerre M; Warin JF; Benchimol D; Le Métayer P; Regaudie JJ; Blanchot P
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):357-63. PubMed ID: 3113358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Short- and medium-term treatment of ventricular hyperkinetic arrhythmia with flecainide].
    Gallicchio F; Aragona PL; Chiatto M; Pugliese F; Donnangelo L
    Clin Ter; 1989 May; 129(3):173-84. PubMed ID: 2527112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flecainide for supraventricular tachycardia in children.
    Zeigler V; Gillette PC; Hammill B; Ross BA; Ewing L
    Am J Cardiol; 1988 Aug; 62(6):41D-43D. PubMed ID: 3136635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flecainide for supraventricular and ventricular arrhythmias in children and young adults.
    Zeigler V; Gillette PC; Ross BA; Ewing L
    Am J Cardiol; 1988 Oct; 62(10 Pt 1):818-20. PubMed ID: 3138905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.